Gustavo P. Amarante-Mendes is a Full Professor and Vice-Dean of Immunology at the Instituto de Ciências Biomédicas, Universidade de São Paulo (ICB-USP). He acted as Secretary (2004-2005) and Vice-President (2012-2013) and is now the President (2016-2017) of the Brazilian Society of Immunology. He is the Vice-President of the Federation of the Societies for Experimental Biology (2017-2019). He was the President of the Biosafety Commission (2009-2013) and Coordinator (2011-2015) of the Post-graduate Program in Immunology of the ICB-USP. He obtained his Bachelor Degree at de Santo Amaro University (1984), and his MSc (1989) and PhD (1993) degrees in Immunology at the University of São Paulo. He was a Research Associate at the La Jolla Institute for Allergy and Immunology (San Diego, CA) and Visiting Scientist at the Department of Genetics, Trinity College Dublin. He is a member of the Editorial Board of the Cell Death and Disease, a journal belonging to the NATURE Publishing Grou and the Frontiers in Cell and Developmental Biology and Frontiers in Immunology. He is also part of the Editorial Advisory Panel of the Biochemical Journal and is one of the Keystone Symposia Programming Consultants. He received many scientific awards, including the 2o Prêmio Oncologia Novartis - Saúde Brasil, Nature Review Cancer Award in 2007 (aluno de doutorado Daniel Diniz de Carvalho), Menção Honrosa at the Prêmio CAPES de Tese em 2009 (aluno Ricardo Weinlich) and the Premio CAPES de Tese em 2010 (aluno Daniel Diniz de Carvalho). He published more than 100 scientific articles and has over 6.000 citations (Google Scholar). He has experience in Immunology, Molecular and Cellular Biology and Experimental Oncology, acting on the following subjects: cell death, apoptosis, signaling transduction, immuneregulation, oncogenes, chronic mieloid leukemia, melanoma. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
O Instituto de Ciências Biomédicas da Universidade de São Paulo detém vocação para a condução de pesquisa básica, aplicada e clínica na área de saúde, bem como em inovação e biotecnologia. A consolidação de tal vocação é representada pela extensa produção científica de nossa comunidade em concomitância à formação e capacitação continuada de pessoal associado à atividade de pesquisa em tod…
CD8+ T lymphocyte-mediated immune response are crucial to fight intracellular pathogens, including viruses, and tumors. Both entities represent huge challenge to health care, particularly because pathogens and tumors are extremely capable of evading the immune response. Recently, SARS-Cov2-driven pandemic has destabilized the whole world at the health, social and financial point of view. …
The Institute of Biomedical Sciences of the University of São Paulo has vocation for conducting basic, applied and clinical research in health, as well as innovation and biotechnology. The consolidation of this vocation is represented by the extensive scientific production of our community, concomitantly with the continuing education and training of personnel associated with research acti…
Melanoma is the most lethal type of skin cancer, caused by the transformation of melanocytes, cells that promote pigmentation of the skin. Melanoma can be divided into four distinct groups, with the two most prevalent presenting modified sequences of B-Raf (52%) or Ras proteins (28%). Ras is the most altered protein in solid tumors and its effectors may be good therapeutic targets. Member…
(Only some records are available in English at this moment)
The Immune System consists in a range of cellular and molecular mechanisms that promote host defense against pathogens and potentially harmful substances. The development of immune responses is required to be tightly regulated, since their defensive role needs to be accompanied by protective mechanisms for the organism. Presently, infections driven by intracellular pathogens and cancer re…
Tumor cells, as well as viruses and other intracellular pathogens, are persistently challenging the human organism. In this scenario, the activation and effector function of antigen-specific CD8+ T lymphocytes represents a major immunological response, since these cells can eliminate infected or transformed cells by inducing their demise (apoptosis). This project will investigate the poss…
Although widely described and studied, cancer still has a high lethality, being one of the leading causes of death in the world. Several mechanisms and treatments have already been and are being developed to try to curb this lethality. The main defense mechanism of the human body is the immune system and, for cancer in particular, the main cells responsible are CD8+ T lymphocytes, known a…
Macrophages are cells that are found in all tissues of the body and that act in various ways on the immune system, for instance, through recognition, phagocytosis and destruction of microorganisms, as well as regulating inflammation and tissue repair. From specific stimuli, these cells differentiate and play their role according to the tissue in which they are present. Interestingly t…
Melanoma is a type of skin neoplasm originated from melanocytes. With the higher rate of mortality among skin cancers, the tumoral process in this disease is strongly linked to the presence of mutations caused by sunlight exposure. The most common mutation is in the BRAF gene, that causes constitutive signaling of cell proliferation pathways. RAF proteins are direct targets of RAS, being …
(Only some records are available in English at this moment)
Cancer remains one of the foremost causes of mortality globally. Tumorigenesis is a multifaceted and progressive process that involves a tumor microenvironment (TME) comprised of various cell types and molecular components, which collectively influence tumor growth, metastasis, and therapeutic response. The intricate interactions between tumor cells and the TME play a pivotal role in canc…
Inflammation is one of the hallmarks of cancer progression and initiation. Constant exposure to inflammatory stimuli can lead to a chronic response that has been highly associated with tumor progression. The main signaling in inflammation occurs through the NF-ºB (nuclear factor ºB) pathway, which has already been shown to be modulated by Ras, acting both as anti and proinflammatory. Ras …
Effective immunotherapy against cancer requires efficient immune responses. The weak immunogenic characteristic of tumor cells contributes to their evasion from immune system. To overcome this, adjuvant signals that promote an inflammatory environment have been proposed as an approach to enhance the antigenicity of tumor cells. Preferential accumulation of pathogenic bacteria in the tumor…
Cancer is a result of a series of events that alter the normal properties of cells. Those cells begin to proliferate uncontrollably, invading tissue and impairing the function of a given system of the body. Cancer cells also have the ability to evade the immune system by a mechanism denominated immunoediting. Therefore, the currently search is for treatments in which the immune system cou…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing grants |
| 20 / 11 | Completed research grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 45 / 24 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 6 / 6 | Completed scholarships abroad |
| 75 / 45 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID